Evidence map›Paper›PMID 37958234›Full record

ArticleDiagnostics (Basel, Switzerland)2023

A Novel Algorithm for Evaluating Bone Metastatic Potential of Breast Cancer through Morphometry and Computational Mathematics.

Simona-Alina Duca-Barbu, Alexandru Adrian Bratei, Antonia-Carmen Lisievici, Tiberiu Augustin Georgescu, Bianca Mihaela Nemes, Maria Sajin, Florinel Pop

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Simona-Alina Duca-BarbuDepartment of Pathology, "Carol Davila" Clinical Nephrology Hospital, 010731 Bucharest, Romania.
Alexandru Adrian BrateiFaculty of Chemical Engineering and Biotechnologies, University Politehnica of Bucharest, 011061 Bucharest, Romania.ORCID 0000-0003-3758-2289
Antonia-Carmen LisieviciDepartment of Pathology, "Carol Davila" Clinical Nephrology Hospital, 010731 Bucharest, Romania.ORCID 0000-0003-0044-4931
Tiberiu Augustin GeorgescuDepartment of Pathology, University of Medicine and Pharmacy "Carol Davila", 020022 Bucharest, Romania.ORCID 0000-0003-2707-1880
Bianca Mihaela NemesInternational Computer High School of Bucharest, 032622 Bucharest, Romania.
Maria SajinDepartment of Pathology, University of Medicine and Pharmacy "Carol Davila", 020022 Bucharest, Romania.
Florinel PopDepartment of Pathology, "Carol Davila" Clinical Nephrology Hospital, 010731 Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone metastases represent about 70% of breast cancer metastases and are associated with worse prognosis as the tumor cells acquire more aggressive features. The selection and investigation of patients with a high risk of developing bone metastasis would have a significant impact on patients' management and survival. The patients were selected from the database of Carol Davila Clinical Nephrology Hospital of Bucharest. Their tumor specimens were pathologically processed, and a representative area was selected. This area was scanned using an Olympus VS200 slide scanner and further analyzed using QuPath software v0.4.4. A representative group of approximately 60-100 tumor cells was selected from each section, for which the following parameters were analyzed: nuclear area, nuclear perimeter, long axis and cell surface. Starting from these measurements, the following were calculated: the mean nuclear area and mean nuclear volume, the nucleus to cytoplasm ratio, the length of the two axes, the long axis to short axis ratio, the acyclicity and anellipticity grade and the mean internuclear distance. The tumor cells belonging to patients known to have bone metastasis seemed to have a lower nuclear area (<55 µm

Indexed as

bone metastasisbreast cancerdigital pathologytumor morphometry

Identifiers

PMID37958234
PMCPMC10650224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.